rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2004-3-18
|
pubmed:abstractText |
The goal of this study was to compare the antithrombotic effects of enoxaparin versus unfractionated heparin (UFH) when combined with eptifibatide in acute coronary syndrome (ACS) patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0735-1097
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
966-71
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15028351-Anticoagulants,
pubmed-meshheading:15028351-Blood Cell Count,
pubmed-meshheading:15028351-Coronary Angiography,
pubmed-meshheading:15028351-Drug Therapy, Combination,
pubmed-meshheading:15028351-Enoxaparin,
pubmed-meshheading:15028351-Female,
pubmed-meshheading:15028351-Heparin,
pubmed-meshheading:15028351-Humans,
pubmed-meshheading:15028351-Male,
pubmed-meshheading:15028351-Middle Aged,
pubmed-meshheading:15028351-Myocardial Infarction,
pubmed-meshheading:15028351-Partial Thromboplastin Time,
pubmed-meshheading:15028351-Peptides,
pubmed-meshheading:15028351-Platelet Aggregation,
pubmed-meshheading:15028351-Platelet Aggregation Inhibitors,
pubmed-meshheading:15028351-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:15028351-Treatment Outcome,
pubmed-meshheading:15028351-Venous Thrombosis
|
pubmed:year |
2004
|
pubmed:articleTitle |
Administration of eptifibatide to acute coronary syndrome patients receiving enoxaparin or unfractionated heparin: effect on platelet function and thrombus formation.
|
pubmed:affiliation |
Cardiology Department, Rabin Medical Center, 39 Jabotinski Street, Petah-Tikva 49100, Israel.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|